SYNAPTICS Inc — Director's Dealing 2020

Feb 12, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SYNAPTICS Inc (SYNA)
CIK: 0000817720
Period of Report: 2020-02-10

Reporting Person: NOLAN KERMIT (See Remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-10	Common Stock	M	9792	$31.73	Acquired	65175	Direct
2020-02-10	Common Stock	M	1000	$39.80	Acquired	66175	Direct
2020-02-10	Common Stock	M	744	$46.50	Acquired	66919	Direct
2020-02-10	Common Stock	S	6877	$81.86	Disposed	60042	Direct
2020-02-10	Common Stock	S	3830	$82.56	Disposed	56212	Direct
2020-02-10	Common Stock	S	829	$83.64	Disposed	55383	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-10	Employee Stock Option (Right to Buy)	$31.73	M	9792	Disposed	2020-08-02	Common Stock (9792)	Direct
2020-02-10	Employee Stock Option (Right to Buy)	$39.80	M	1000	Disposed	2020-08-05	Common Stock (1000)	Direct
2020-02-10	Employee Stock Option (Right to Buy)	$46.50	M	744	Disposed	2020-10-28	Common Stock (744)	Direct

Footnotes

F1: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 21, 2019.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.28 to $82.27, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.29 to $83.18, inclusive. The reporting person undertakes to provide to the Company any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.37 to $83.99, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: 1/48th of the total number of shares subject to the option vested and became exercisable on the 2nd day of each month following the August 2, 2010 date of the grant until fully vested on August 2, 2014.

F6: 1/36th of the total number of shares subject to the option vested and became exercisable on the 5th day of each month following the August 5, 2013 date of grant until fully vested on August 5, 2016.

F7: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the October 28, 2013 date of grant until fully vested on October 28, 2016.